Validation of hPTM-001, a humanized candidate therapeutic antibody for promoting mucosal wound healing in IBD. Liang TW, Presta LG, Brazil JC, Parkos CA, Cheng JC. Poster presented at Crohn’s & Colitis Congress 2021, Jan 21-24, 2021.